Latest BC Cancer Agency Stories
Demonstrates Technology Suitable & Scalable for Multiple Brands of Cyclotrons ST.
Scientists at the BC Cancer Agency, Vancouver Coastal Health Research Institute, and the University of British Columbia are excited over a discovery made while studying rare tumor types.
The results of a pilot study on lung cancer detection will be published in the prestigious Journal of Thoracic Oncology in July Vancouver, Canada (PRWEB) July 06, 2011 Verisante Technology, Inc.
Verisante purchases endoscopy systems for early lung cancer detection to compliment Verisante Core Vancouver, Canada (PRWEB) June 13, 2011 Verisante Technology, Inc.
BALTIMORE, Md., April 1, 2011 /PRNewswire/ -- Champions Biotechnology, Inc. (OTC: CSBR) ("Champions" or "the Company") announced today that it has exercised an option to license Irinophore C(TM), a liposomal formulation of Irinotecan, from the BC Cancer Agency ("BCCA") in British Columbia, Canada.
Eureka! Vancouver scientists from the Ovarian Cancer Research (OvCaRe) Program at BC Cancer Agency and Vancouver Coastal Health Research Institute have discovered that there appears to be a single spelling mistake in the genetic code of granulosa cell tumours, a rare and often untreatable form of ovarian cancer.
- totally perplexed and mixed up.